Abstract:BackgroundTreatment with tocilizumab has been associated with an increase in transaminase levels which may be related to treatment discontinuation.PurposeTo examine changes of transaminase levels (AST/ALT) in patients with rheumatic diseases treated with tocilizumab, as well as analyse the checking interventions.Material and methodsRetrospective observational study. Patients on treatment with tocilizumab between January 2007 and July 2014 were included. The data collected were: demographic, diagnosis, duration… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.